The Ensign Group, Inc.
The Ensign Group, Inc. ENSG Peers
See (ENSG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENSG | $154.65 | +1.39% | 8.8B | 29.02 | $5.30 | +0.16% |
| HCA | $382.44 | +2.20% | 90.9B | 16.57 | $22.80 | +0.73% |
| BKDT | $77.60 | +0.00% | 16.6B | N/A | N/A | N/A |
| FMS | $28.27 | +1.95% | 16.5B | 23.22 | $1.21 | +2.80% |
| THC | $174.52 | +3.26% | 16B | 11.06 | $15.60 | N/A |
| SOLV | $75.13 | +0.24% | 12.9B | 34.38 | $2.17 | N/A |
| EHC | $122.51 | +1.52% | 12.2B | 25.01 | $4.86 | +0.55% |
| UHS | $180.20 | +2.57% | 11.4B | 9.96 | $17.81 | +0.45% |
| DVA | $142.52 | +1.54% | 10.7B | 14.00 | $10.08 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
ENSG vs HCA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, HCA has a market cap of 90.9B. Regarding current trading prices, ENSG is priced at $154.65, while HCA trades at $382.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas HCA's P/E ratio is 16.57. In terms of profitability, ENSG's ROE is +0.17%, compared to HCA's ROE of -2.36%. Regarding short-term risk, ENSG is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs BKDT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, BKDT has a market cap of 16.6B. Regarding current trading prices, ENSG is priced at $154.65, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas BKDT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, ENSG is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs FMS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, FMS has a market cap of 16.5B. Regarding current trading prices, ENSG is priced at $154.65, while FMS trades at $28.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas FMS's P/E ratio is 23.22. In terms of profitability, ENSG's ROE is +0.17%, compared to FMS's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs THC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, THC has a market cap of 16B. Regarding current trading prices, ENSG is priced at $154.65, while THC trades at $174.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas THC's P/E ratio is 11.06. In terms of profitability, ENSG's ROE is +0.17%, compared to THC's ROE of +0.37%. Regarding short-term risk, ENSG is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SOLV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SOLV has a market cap of 12.9B. Regarding current trading prices, ENSG is priced at $154.65, while SOLV trades at $75.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SOLV's P/E ratio is 34.38. In terms of profitability, ENSG's ROE is +0.17%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, ENSG is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs EHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, EHC has a market cap of 12.2B. Regarding current trading prices, ENSG is priced at $154.65, while EHC trades at $122.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas EHC's P/E ratio is 25.01. In terms of profitability, ENSG's ROE is +0.17%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ENSG is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs UHS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, UHS has a market cap of 11.4B. Regarding current trading prices, ENSG is priced at $154.65, while UHS trades at $180.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas UHS's P/E ratio is 9.96. In terms of profitability, ENSG's ROE is +0.17%, compared to UHS's ROE of +0.18%. Regarding short-term risk, ENSG is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs DVA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, DVA has a market cap of 10.7B. Regarding current trading prices, ENSG is priced at $154.65, while DVA trades at $142.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas DVA's P/E ratio is 14.00. In terms of profitability, ENSG's ROE is +0.17%, compared to DVA's ROE of +3.94%. Regarding short-term risk, ENSG is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs OSH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, ENSG is priced at $154.65, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas OSH's P/E ratio is -17.65. In terms of profitability, ENSG's ROE is +0.17%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ENSG is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CHE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CHE has a market cap of 8.1B. Regarding current trading prices, ENSG is priced at $154.65, while CHE trades at $560.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CHE's P/E ratio is 27.13. In terms of profitability, ENSG's ROE is +0.17%, compared to CHE's ROE of +0.26%. Regarding short-term risk, ENSG is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs LHCG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, ENSG is priced at $154.65, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ENSG's ROE is +0.17%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs OPCH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, OPCH has a market cap of 5.2B. Regarding current trading prices, ENSG is priced at $154.65, while OPCH trades at $32.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas OPCH's P/E ratio is 25.60. In terms of profitability, ENSG's ROE is +0.17%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, ENSG is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMED Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, ENSG is priced at $154.65, while AMED trades at $98.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AMED's P/E ratio is 36.17. In terms of profitability, ENSG's ROE is +0.17%, compared to AMED's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SGRY Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SGRY has a market cap of 2.8B. Regarding current trading prices, ENSG is priced at $154.65, while SGRY trades at $21.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SGRY's P/E ratio is -14.18. In terms of profitability, ENSG's ROE is +0.17%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, ENSG is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs ADUS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, ENSG is priced at $154.65, while ADUS trades at $115.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ADUS's P/E ratio is 26.12. In terms of profitability, ENSG's ROE is +0.17%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, ENSG is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs ACHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ACHC has a market cap of 2B. Regarding current trading prices, ENSG is priced at $154.65, while ACHC trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ACHC's P/E ratio is 10.81. In terms of profitability, ENSG's ROE is +0.17%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs LFST Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, LFST has a market cap of 2B. Regarding current trading prices, ENSG is priced at $154.65, while LFST trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas LFST's P/E ratio is -56.44. In terms of profitability, ENSG's ROE is +0.17%, compared to LFST's ROE of -0.02%. Regarding short-term risk, ENSG is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SEM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SEM has a market cap of 1.9B. Regarding current trading prices, ENSG is priced at $154.65, while SEM trades at $15.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SEM's P/E ratio is 24.24. In terms of profitability, ENSG's ROE is +0.17%, compared to SEM's ROE of +0.10%. Regarding short-term risk, ENSG is less volatile compared to SEM. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ARDT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ARDT has a market cap of 1.9B. Regarding current trading prices, ENSG is priced at $154.65, while ARDT trades at $13.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ARDT's P/E ratio is 7.92. In terms of profitability, ENSG's ROE is +0.17%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, ENSG is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMEH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, ENSG is priced at $154.65, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ENSG's ROE is +0.17%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, ENSG is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs NHC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, NHC has a market cap of 1.7B. Regarding current trading prices, ENSG is priced at $154.65, while NHC trades at $108.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas NHC's P/E ratio is 15.76. In terms of profitability, ENSG's ROE is +0.17%, compared to NHC's ROE of +0.11%. Regarding short-term risk, ENSG is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs BKD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, BKD has a market cap of 1.6B. Regarding current trading prices, ENSG is priced at $154.65, while BKD trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas BKD's P/E ratio is -6.72. In terms of profitability, ENSG's ROE is +0.17%, compared to BKD's ROE of -0.96%. Regarding short-term risk, ENSG is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ASTH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ASTH has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $154.65, while ASTH trades at $24.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ASTH's P/E ratio is 33.86. In terms of profitability, ENSG's ROE is +0.17%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, ENSG is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs USPH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $154.65, while USPH trades at $79.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas USPH's P/E ratio is 36.15. In terms of profitability, ENSG's ROE is +0.17%, compared to USPH's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to USPH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, MD has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $154.65, while MD trades at $13.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas MD's P/E ratio is -13.62. In terms of profitability, ENSG's ROE is +0.17%, compared to MD's ROE of -0.11%. Regarding short-term risk, ENSG is less volatile compared to MD. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs HCSG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, HCSG has a market cap of 1.1B. Regarding current trading prices, ENSG is priced at $154.65, while HCSG trades at $14.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas HCSG's P/E ratio is 27.07. In terms of profitability, ENSG's ROE is +0.17%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, ENSG is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs PNTG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, PNTG has a market cap of 1B. Regarding current trading prices, ENSG is priced at $154.65, while PNTG trades at $29.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas PNTG's P/E ratio is 38.28. In terms of profitability, ENSG's ROE is +0.17%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, ENSG is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AGL Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AGL has a market cap of 956.2M. Regarding current trading prices, ENSG is priced at $154.65, while AGL trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AGL's P/E ratio is -3.73. In terms of profitability, ENSG's ROE is +0.17%, compared to AGL's ROE of -0.44%. Regarding short-term risk, ENSG is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AVAH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AVAH has a market cap of 939.4M. Regarding current trading prices, ENSG is priced at $154.65, while AVAH trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AVAH's P/E ratio is 160.50. In terms of profitability, ENSG's ROE is +0.17%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, ENSG is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMN Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AMN has a market cap of 805.1M. Regarding current trading prices, ENSG is priced at $154.65, while AMN trades at $21.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AMN's P/E ratio is -4.86. In terms of profitability, ENSG's ROE is +0.17%, compared to AMN's ROE of -0.21%. Regarding short-term risk, ENSG is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs INNV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, INNV has a market cap of 534.7M. Regarding current trading prices, ENSG is priced at $154.65, while INNV trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas INNV's P/E ratio is -16.50. In terms of profitability, ENSG's ROE is +0.17%, compared to INNV's ROE of -0.12%. Regarding short-term risk, ENSG is more volatile compared to INNV. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CYH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CYH has a market cap of 488.3M. Regarding current trading prices, ENSG is priced at $154.65, while CYH trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CYH's P/E ratio is -0.95. In terms of profitability, ENSG's ROE is +0.17%, compared to CYH's ROE of +0.30%. Regarding short-term risk, ENSG is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs EHAB Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, EHAB has a market cap of 482.6M. Regarding current trading prices, ENSG is priced at $154.65, while EHAB trades at $9.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas EHAB's P/E ratio is -3.44. In terms of profitability, ENSG's ROE is +0.17%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, ENSG is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs TALKW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TALKW has a market cap of 481.6M. Regarding current trading prices, ENSG is priced at $154.65, while TALKW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TALKW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, ENSG is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AUNA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AUNA has a market cap of 471.5M. Regarding current trading prices, ENSG is priced at $154.65, while AUNA trades at $6.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AUNA's P/E ratio is 10.11. In terms of profitability, ENSG's ROE is +0.17%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, ENSG is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SNDA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SNDA has a market cap of 460.3M. Regarding current trading prices, ENSG is priced at $154.65, while SNDA trades at $24.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SNDA's P/E ratio is -6.72. In terms of profitability, ENSG's ROE is +0.17%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, ENSG is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TALK Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TALK has a market cap of 460.1M. Regarding current trading prices, ENSG is priced at $154.65, while TALK trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TALK's P/E ratio is 137.50. In terms of profitability, ENSG's ROE is +0.17%, compared to TALK's ROE of -0.04%. Regarding short-term risk, ENSG is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCRN Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CCRN has a market cap of 429.8M. Regarding current trading prices, ENSG is priced at $154.65, while CCRN trades at $13.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CCRN's P/E ratio is -24.28. In terms of profitability, ENSG's ROE is +0.17%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, ENSG is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AONC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AONC has a market cap of 392.6M. Regarding current trading prices, ENSG is priced at $154.65, while AONC trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AONC's P/E ratio is -15.12. In terms of profitability, ENSG's ROE is +0.17%, compared to AONC's ROE of +0.25%. Regarding short-term risk, ENSG is less volatile compared to AONC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AIRS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AIRS has a market cap of 296.2M. Regarding current trading prices, ENSG is priced at $154.65, while AIRS trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AIRS's P/E ratio is -16.36. In terms of profitability, ENSG's ROE is +0.17%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, ENSG is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CMPS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CMPS has a market cap of 247M. Regarding current trading prices, ENSG is priced at $154.65, while CMPS trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CMPS's P/E ratio is -1.34. In terms of profitability, ENSG's ROE is +0.17%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, ENSG is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TOIIW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TOIIW has a market cap of 233.4M. Regarding current trading prices, ENSG is priced at $154.65, while TOIIW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TOIIW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, ENSG is more volatile compared to TOIIW. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CSU Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, ENSG is priced at $154.65, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CSU's P/E ratio is 0.67. In terms of profitability, ENSG's ROE is +0.17%, compared to CSU's ROE of +2.23%. Regarding short-term risk, ENSG is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TOI Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TOI has a market cap of 205.9M. Regarding current trading prices, ENSG is priced at $154.65, while TOI trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TOI's P/E ratio is -3.20. In terms of profitability, ENSG's ROE is +0.17%, compared to TOI's ROE of -4.83%. Regarding short-term risk, ENSG is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs JYNT Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, JYNT has a market cap of 177.7M. Regarding current trading prices, ENSG is priced at $154.65, while JYNT trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas JYNT's P/E ratio is -116.10. In terms of profitability, ENSG's ROE is +0.17%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, ENSG is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs DCGO Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, DCGO has a market cap of 167.5M. Regarding current trading prices, ENSG is priced at $154.65, while DCGO trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas DCGO's P/E ratio is -169.00. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, ENSG is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs BTMD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, BTMD has a market cap of 163.9M. Regarding current trading prices, ENSG is priced at $154.65, while BTMD trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas BTMD's P/E ratio is 7.38. In terms of profitability, ENSG's ROE is +0.17%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, ENSG is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs FVE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, ENSG is priced at $154.65, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas FVE's P/E ratio is -5.64. In terms of profitability, ENSG's ROE is +0.17%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ENSG is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs KDLYW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, ENSG is priced at $154.65, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, ENSG is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MODV Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, MODV has a market cap of 50.5M. Regarding current trading prices, ENSG is priced at $154.65, while MODV trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas MODV's P/E ratio is -0.22. In terms of profitability, ENSG's ROE is +0.17%, compared to MODV's ROE of +6.87%. Regarding short-term risk, ENSG is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ALR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, ENSG is priced at $154.65, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ALR's P/E ratio is -1.11. In terms of profitability, ENSG's ROE is +0.17%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCEL Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CCEL has a market cap of 42.1M. Regarding current trading prices, ENSG is priced at $154.65, while CCEL trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CCEL's P/E ratio is 520.50. In terms of profitability, ENSG's ROE is +0.17%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, ENSG is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs IMAC Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, ENSG is priced at $154.65, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ENSG's ROE is +0.17%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, ENSG is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs PIII Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, PIII has a market cap of 20.2M. Regarding current trading prices, ENSG is priced at $154.65, while PIII trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas PIII's P/E ratio is -0.12. In terms of profitability, ENSG's ROE is +0.17%, compared to PIII's ROE of -1.29%. Regarding short-term risk, ENSG is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AIH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, ENSG is priced at $154.65, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AIH's P/E ratio is -2.78. In terms of profitability, ENSG's ROE is +0.17%, compared to AIH's ROE of +1.16%. Regarding short-term risk, ENSG is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs AMS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, AMS has a market cap of 15.5M. Regarding current trading prices, ENSG is priced at $154.65, while AMS trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas AMS's P/E ratio is 11.42. In terms of profitability, ENSG's ROE is +0.17%, compared to AMS's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CANO Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, ENSG is priced at $154.65, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CANO's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO's ROE of -1.49%. Regarding short-term risk, ENSG is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs FTRP Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, ENSG is priced at $154.65, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ENSG's ROE is +0.17%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ENSG is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs GBNH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, ENSG is priced at $154.65, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, ENSG is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs RHE Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, ENSG is priced at $154.65, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas RHE's P/E ratio is -1.79. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE's ROE of +1.52%. Regarding short-term risk, ENSG is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs MNDR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, MNDR has a market cap of 4.9M. Regarding current trading prices, ENSG is priced at $154.65, while MNDR trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas MNDR's P/E ratio is -0.16. In terms of profitability, ENSG's ROE is +0.17%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, ENSG is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs ATIP Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, ATIP has a market cap of 3.8M. Regarding current trading prices, ENSG is priced at $154.65, while ATIP trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas ATIP's P/E ratio is -0.04. In terms of profitability, ENSG's ROE is +0.17%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, ENSG is more volatile compared to ATIP. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs IMACW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, ENSG is priced at $154.65, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas IMACW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, ENSG is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SYRA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SYRA has a market cap of 1.2M. Regarding current trading prices, ENSG is priced at $154.65, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SYRA's P/E ratio is -0.31. In terms of profitability, ENSG's ROE is +0.17%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, ENSG is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs NIVFW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, NIVFW has a market cap of 1.1M. Regarding current trading prices, ENSG is priced at $154.65, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas NIVFW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, ENSG is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs CCM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, CCM has a market cap of 804.8K. Regarding current trading prices, ENSG is priced at $154.65, while CCM trades at $5.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas CCM's P/E ratio is -0.56. In terms of profitability, ENSG's ROE is +0.17%, compared to CCM's ROE of +0.13%. Regarding short-term risk, ENSG is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs RHE-PA Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, ENSG is priced at $154.65, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, ENSG is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs BACK Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, BACK has a market cap of 189.6K. Regarding current trading prices, ENSG is priced at $154.65, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas BACK's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to BACK's ROE of +2.46%. Regarding short-term risk, ENSG is less volatile compared to BACK. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs IONM Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, IONM has a market cap of 149.8K. Regarding current trading prices, ENSG is priced at $154.65, while IONM trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas IONM's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IONM's ROE of +0.75%. Regarding short-term risk, ENSG is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs NVOS Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, NVOS has a market cap of 78.9K. Regarding current trading prices, ENSG is priced at $154.65, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas NVOS's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, ENSG is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs PIIIW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, PIIIW has a market cap of 33.3K. Regarding current trading prices, ENSG is priced at $154.65, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, ENSG is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TLMD Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TLMD's P/E ratio is -1.60. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, ENSG is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs DCGOW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas DCGOW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, ENSG is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs NFH Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, NFH has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas NFH's P/E ratio is -19.75. In terms of profitability, ENSG's ROE is +0.17%, compared to NFH's ROE of -0.06%. Regarding short-term risk, ENSG is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs HNGR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas HNGR's P/E ratio is 19.71. In terms of profitability, ENSG's ROE is +0.17%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, ENSG is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs DVCR Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas DVCR's P/E ratio is 28.34. In terms of profitability, ENSG's ROE is +0.17%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs SLHG Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SLHG's P/E ratio is -1.48. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHG's ROE of N/A. Regarding short-term risk, ENSG is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs SLHGP Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, ENSG is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.
ENSG vs TLMDW Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TLMDW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, ENSG is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for ENSG.
ENSG vs TVTY Comparison
ENSG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 8.8B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, ENSG is priced at $154.65, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 29.02, whereas TVTY's P/E ratio is 19.06. In terms of profitability, ENSG's ROE is +0.17%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, ENSG is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for ENSG.